Wang XD - Search Results

1

Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy.

Chen YJ, Li GN, Li XJ, Wei LX, Fu MJ, Cheng ZL, Yang Z, Zhu GQ, Wang XD, Zhang C, Zhang JY, Sun YP, Saiyin H, Zhang J, Liu WR, Zhu WW, Guan KL, Xiong Y, Yang Y, Ye D, Chen LL. Chen YJ, et al. Among authors: wang xd. Sci Adv. 2023 Apr 28;9(17):eadg0654. doi: 10.1126/sciadv.adg0654. Epub 2023 Apr 28. Sci Adv. 2023. PMID: 37115931 Free PMC article.

2

Induced CAR-Macrophages as a Novel Therapeutic Cell Type for Cancer Immune Cell Therapies.

Su S, Lei A, Wang X, Lu H, Wang S, Yang Y, Li N, Zhang Y, Zhang J. Su S, et al. Cells. 2022 May 16;11(10):1652. doi: 10.3390/cells11101652. Cells. 2022. PMID: 35626689 Free PMC article. Review.

3

Targeted glycan degradation potentiates cellular immunotherapy for solid tumors.

Wu J, Wang X, Huang Y, Zhang Y, Su S, Shou H, Wang H, Zhang J, Wang B. Wu J, et al. Proc Natl Acad Sci U S A. 2023 Sep 19;120(38):e2300366120. doi: 10.1073/pnas.2300366120. Epub 2023 Sep 11. Proc Natl Acad Sci U S A. 2023. PMID: 37695897 Free PMC article.

4

Metabolic Reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors.

Wang X, Su S, Zhu Y, Cheng X, Cheng C, Chen L, Lei A, Zhang L, Xu Y, Ye D, Zhang Y, Li W, Zhang J. Wang X, et al. Nat Commun. 2023 Sep 18;14(1):5778. doi: 10.1038/s41467-023-41470-9. Nat Commun. 2023. PMID: 37723178 Free PMC article.

5

Metabolic reprogramming of macrophages in cancer therapy.

Wang X, Zhang S, Xue D, Neculai D, Zhang J. Wang X, et al. Trends Endocrinol Metab. 2024 Sep 19:S1043-2760(24)00244-3. doi: 10.1016/j.tem.2024.08.009. Online ahead of print. Trends Endocrinol Metab. 2024. PMID: 39304355 Review.

6

Strategies for Genetically Engineering Hypoimmunogenic Universal Pluripotent Stem Cells.

Zhao W, Lei A, Tian L, Wang X, Correia C, Weiskittel T, Li H, Trounson A, Fu Q, Yao K, Zhang J. Zhao W, et al. iScience. 2020 Jun 26;23(6):101162. doi: 10.1016/j.isci.2020.101162. Epub 2020 May 17. iScience. 2020. PMID: 32502965 Free PMC article. Review.

7

A second-generation M1-polarized CAR macrophage with antitumor efficacy.

Lei A, Yu H, Lu S, Lu H, Ding X, Tan T, Zhang H, Zhu M, Tian L, Wang X, Su S, Xue D, Zhang S, Zhao W, Chen Y, Xie W, Zhang L, Zhu Y, Zhao J, Jiang W, Church G, Chan FK, Gao Z, Zhang J. Lei A, et al. Nat Immunol. 2024 Jan;25(1):102-116. doi: 10.1038/s41590-023-01687-8. Epub 2023 Nov 27. Nat Immunol. 2024. PMID: 38012418

8

Author Correction: A second-generation M1-polarized CAR macrophage with antitumor efficacy.

Lei A, Yu H, Lu S, Lu H, Ding X, Tan T, Zhang H, Zhu M, Tian L, Wang X, Su S, Xue D, Zhang S, Zhao W, Chen Y, Xie W, Zhang L, Zhu Y, Zhao J, Jiang W, Church G, Chan FK, Gao Z, Zhang J. Lei A, et al. Nat Immunol. 2024 Mar;25(3):576. doi: 10.1038/s41590-023-01734-4. Nat Immunol. 2024. PMID: 38110523 No abstract available.

9

An important role of a "probable ATP-binding component of ABC transporter" during the process of Pseudomonas aeruginosa resistance to fluoroquinolone.

Zhou J, Hao D, Wang X, Liu T, He C, Xie F, Sun Y, Zhang J. Zhou J, et al. Proteomics. 2006 Apr;6(8):2495-503. doi: 10.1002/pmic.200501354. Proteomics. 2006. PMID: 16526085

10

Guajadial reverses multidrug resistance by inhibiting ABC transporter expression and suppressing the PI3K/Akt pathway in drug-resistant breast cancer cells.

Li Y, Zhai Z, Li H, Wang X, Huang Y, Su X. Li Y, et al. Chem Biol Interact. 2019 May 25;305:98-104. doi: 10.1016/j.cbi.2019.03.032. Epub 2019 Mar 28. Chem Biol Interact. 2019. PMID: 30929998

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,914 results

Search Page

Filters